The transcription factor CREB (cAMP Response-Element Binding Protein) is overexpressed in the majority of acute myeloid leukemia (AML) patients, and this is associated with a worse prognosis. Previous work revealed that CREB overexpression augmented AML cell growth, while CREB knockdown disrupted key AML cell functions in vitro. In contrast, CREB knockdown had no effect on long-term hematopoietic stem cell activity in mouse transduction/transplantation assays. Together, these studies position CREB as a promising drug target for AML. To test this concept, a small molecule inhibitor of CREB, XX-650-23, was developed. This molecule blocks a critical interaction between CREB and its required co-activator CBP (CREB Binding Protein), leading to disruption of CREB-driven gene expression. Inhibition of CBP-CREB interaction induced apoptosis and cell-cycle arrest in AML cells, and prolonged survival in vivo in mice injected with human AML cells. XX-650-23 had little toxicity on normal human hematopoietic cells and tissues in mice. To understand the mechanism of XX-650-23, we performed RNA-seq, ChIP-seq and Cytometry Time of Flight with human AML cells. Our results demonstrate that small molecule inhibition of CBP-CREB interaction mostly affects apoptotic, cell-cycle and survival pathways, which may represent a novel approach for AML therapy.Leukemia advance online publication, 10 June 2016; doi:10.1038/leu.2016.139.

Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells / Mitton, B; Chae, H-D; Hsu, K; Dutta, R; Aldana-Masangkay, G; Ferrari, R; Davis, K; Tiu, B C; Kaul, A; Lacayo, N; Dahl, G; Xie, F; Li, B X; Breese, M R; Landaw, E M; Nolan, G; Pellegrini, M; Romanov, S; Xiao, X; Sakamoto, K M. - In: LEUKEMIA. - ISSN 0887-6924. - (2016). [10.1038/leu.2016.139]

Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells

Ferrari R;
2016-01-01

Abstract

The transcription factor CREB (cAMP Response-Element Binding Protein) is overexpressed in the majority of acute myeloid leukemia (AML) patients, and this is associated with a worse prognosis. Previous work revealed that CREB overexpression augmented AML cell growth, while CREB knockdown disrupted key AML cell functions in vitro. In contrast, CREB knockdown had no effect on long-term hematopoietic stem cell activity in mouse transduction/transplantation assays. Together, these studies position CREB as a promising drug target for AML. To test this concept, a small molecule inhibitor of CREB, XX-650-23, was developed. This molecule blocks a critical interaction between CREB and its required co-activator CBP (CREB Binding Protein), leading to disruption of CREB-driven gene expression. Inhibition of CBP-CREB interaction induced apoptosis and cell-cycle arrest in AML cells, and prolonged survival in vivo in mice injected with human AML cells. XX-650-23 had little toxicity on normal human hematopoietic cells and tissues in mice. To understand the mechanism of XX-650-23, we performed RNA-seq, ChIP-seq and Cytometry Time of Flight with human AML cells. Our results demonstrate that small molecule inhibition of CBP-CREB interaction mostly affects apoptotic, cell-cycle and survival pathways, which may represent a novel approach for AML therapy.Leukemia advance online publication, 10 June 2016; doi:10.1038/leu.2016.139.
2016
Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells / Mitton, B; Chae, H-D; Hsu, K; Dutta, R; Aldana-Masangkay, G; Ferrari, R; Davis, K; Tiu, B C; Kaul, A; Lacayo, N; Dahl, G; Xie, F; Li, B X; Breese, M R; Landaw, E M; Nolan, G; Pellegrini, M; Romanov, S; Xiao, X; Sakamoto, K M. - In: LEUKEMIA. - ISSN 0887-6924. - (2016). [10.1038/leu.2016.139]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2874926
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 27
social impact